Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium.

Ilan U, Rubio-San-Simón A, van Eijkelenburg N, Owens C, Kraus A, Moreno L, Carceller F, Lecinse C, Knox L, Scobie N, Geoerger B, Zwaan CM, Kearns P, Bautista F, Innovative Therapies For Children and Adolescents With Cancer Consortium (ITCC).

Open source

DOI: 10.1016/j.ejca.2026.116830
Published: 2026 Jun 25
Container: European journal of cancer (Oxford, England : 1990)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.116830,
  title = {Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium.},
  author = {Ilan U and Rubio-San-Simón A and van Eijkelenburg N and Owens C and Kraus A and Moreno L and Carceller F and Lecinse C and Knox L and Scobie N and Geoerger B and Zwaan CM and Kearns P and Bautista F and Innovative Therapies For Children and Adolescents With Cancer Consortium (ITCC).},
  year = {2026},
  journal = {European journal of cancer (Oxford, England : 1990)},
  doi = {10.1016/j.ejca.2026.116830},
  url = {https://doi.org/10.1016/j.ejca.2026.116830}
}

RIS

TY  - JOUR
TI  - Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium.
AU  - Ilan U
AU  - Rubio-San-Simón A
AU  - van Eijkelenburg N
AU  - Owens C
AU  - Kraus A
AU  - Moreno L
AU  - Carceller F
AU  - Lecinse C
AU  - Knox L
AU  - Scobie N
AU  - Geoerger B
AU  - Zwaan CM
AU  - Kearns P
AU  - Bautista F
AU  - Innovative Therapies For Children and Adolescents With Cancer Consortium (ITCC).
PY  - 2026
JO  - European journal of cancer (Oxford, England : 1990)
DO  - 10.1016/j.ejca.2026.116830
UR  - https://doi.org/10.1016/j.ejca.2026.116830
ER  -

APA

U, I., A, R., N, V. E., C, O., A, K., L, M., F, C., C, L., L, K., N, S., B, G., CM, Z., P, K., F, B., & (ITCC)., I. T. F. C. A. A. W. C. C. (2026). Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2026.116830

Source records

pubmed · retrieved 2026-09-25T04:23:14.385Z